On peptides

GHK-Cu Copper Peptide: 50 Years of Research, Explained

The full story on GHK-Cu — discovered in 1973, studied for half a century, and finally a staple in well-formulated peptide skincare. Here's what the research actually shows.

8 min read · Aperture Skin

GHK-Cu Copper Peptide: 50 Years of Research, Explained

GHK-Cu is unusual in cosmetic chemistry: it’s not a synthetic ingredient invented by a lab to look good on a label. It’s a peptide that occurs naturally in human plasma, was first isolated in 1973, and has been studied continuously for over half a century. The published research file is one of the deepest of any topical peptide.

That depth is why GHK-Cu has quietly become the standard hero ingredient in well-formulated peptide creams — including ours. This is the long version: the discovery story, the role of the copper ion, the natural decline with age, and what topical use does (and doesn’t) deliver.

The discovery story

In 1973, Dr Loren Pickart was working at the Children’s Hospital Research Foundation in Cincinnati, studying why human plasma from younger donors seemed to keep liver tissue regenerating in vitro better than plasma from older donors. He isolated the active fragment responsible — a tripeptide of three amino acids: glycine, histidine, lysine. The sequence is known as GHK.

Pickart’s later work showed that GHK has a strong affinity for binding a single copper ion. The bound complex — written GHK-Cu, or sometimes copper tripeptide-1 in cosmetic INCI lists — behaves differently from GHK alone. The copper isn’t decoration; it’s part of the active molecule.

GHK-Cu was studied through the 1980s and 1990s primarily in wound-care research, and it’s been used in clinical wound dressings for decades. The cosmetic application — as a topical ingredient in skincare aimed at the appearance of ageing skin — followed in the late 1990s and accelerated through the 2000s as the published file grew.

The role of the copper ion

Copper is a trace element your body needs in small amounts. It’s a cofactor in dozens of enzymes, including the ones involved in connective-tissue formation. The peptide GHK acts as a delivery vehicle — it binds a copper ion and walks it across the cell membrane to where the cell can use it.

This is the “carrier peptide” category referenced in the broader peptide guide. GHK-Cu doesn’t just signal cells to do something. It physically delivers a metabolic cofactor.

Two practical implications.

First, the visible blue-green tint sometimes seen in copper peptide creams is the actual copper. It’s not a pigment added to make the product look medical; it’s an aesthetic side-effect of using GHK-Cu at meaningful concentrations. (Brands that claim to use copper peptides but produce a snow-white cream are usually using a chemically modified or chelated version that loses the colour — and often loses the activity along with it.)

Second, formulating with GHK-Cu is harder than formulating with most synthetic peptides. The copper ion is reactive. Vitamin C, retinol, and certain antioxidants will compete with the copper or destabilise it, changing the colour, the smell, and the activity. A well-formulated copper peptide cream is built specifically to keep the GHK-Cu stable until it lands on your skin.

The natural decline with age

The reason researchers continue to study GHK-Cu fifty years after its discovery is that levels in human plasma decline with age — sharply.

Pickart’s original work and subsequent independent research established that plasma GHK levels in adults under 25 are roughly four times higher than in adults over 60. The decline isn’t linear; it accelerates from middle age onward.

That observation drives the cosmetic use case. The hypothesis is that topical GHK-Cu can supplement a naturally diminishing molecule. The supporting research — across in-vitro studies, animal models, and small-scale human studies — is consistent with topical GHK-Cu influencing the appearance of skin in ways that align with younger-skin behaviour: the look of firmer texture, more even tone, and visibly improved hydration over weeks of consistent use.

What the research does not establish, in a regulated, published, large-scale human-trial sense, is a direct causal link between topical GHK-Cu and reversal of physiological ageing processes. The cosmetic-claim language has to stay in the “appearance of” register. We honour that line on our product pages, and we’d encourage healthy scepticism of brands that don’t.

Topical use today

Cosmetic-grade GHK-Cu is used in serums, creams, eye treatments, and scalp products. The cream format is the most common because of two formulation reasons:

The cream base offers a more stable environment for the copper-bound peptide than a lightweight serum.

The slightly heavier emollient layer helps GHK-Cu stay on the skin long enough to be absorbed; thinner serums evaporate faster.

Concentration matters. Pickart’s published work uses GHK-Cu in the 2% range. Most well-formulated copper peptide creams sit in the 1–3% band. Below 1%, the dose is below what the research used; above 3%, you start seeing the blue-green tint become more pronounced and some skin types finding it slightly drying.

Where it sits in the routine: after cleansing, after a peptide serum (if you’re using one), before sunscreen in the morning or before your LED mask in the evening. Never paired in the same application as vitamin C — the copper and the ascorbic acid will compete and you’ll lose the activity of both.

What topical GHK-Cu does (and doesn’t) do

What it’s been observed to do, in cosmetic-claim language:

  • Support the appearance of more even skin tone over weeks of use
  • Help skin look conditioned and visibly hydrated
  • Contribute to the look of firmer, plumper-looking skin around the cheeks and eyes
  • Visibly improve the appearance of skin texture in some users

What it doesn’t do:

  • Anything overnight. Like all peptide work, GHK-Cu compounds slowly. The 30-day mark is when most users start to notice something.
  • Anything at trace concentrations. Below 1%, the dose isn’t doing the work the research describes.
  • Anything in conflict with vitamin C in the same routine. Use them in different applications (one morning, one night, or one daily and one alternate).

Common questions

Does it really need to be blue-green? A faint tint is the natural sign that the copper is bound and present. It’s not required — chelated forms exist that are colourless — but the colour is a useful visual indicator.

Can I use it during pregnancy? GHK-Cu is generally considered safe in cosmetic use, but as with any topical active, your obstetrician’s call is the one that matters.

How long does a jar last? A 50 ml jar at pea-sized nightly use lasts roughly 60–80 days. Brands sizing jars at 100 ml or larger are usually counting on people using them less consistently — sized for marketing, not for use.

The Aperture Skin take

Copper Peptide Cream uses GHK-Cu (Copper Tripeptide-1) at a meaningful concentration with a formulation specifically built to keep the copper ion stable. The faint blue-green tint is intentional — it’s the GHK-Cu doing its job.

We use it in the routine after Peptide Serum 01, before the LED mask. The copper peptide stays on the skin overnight and the LED mask doesn’t compete with it the way vitamin C would.

The full INCI list is on the product page. The percentage of GHK-Cu sits in the published research range. We don’t claim therapeutic outcomes from any of this — what we claim is what the cosmetic research supports: the appearance of firmer, more conditioned skin over weeks of consistent use.

For the longer scientific version, see The Science page.

Further reading


This article is general information, not personalised skincare advice. Aperture Skin products are cosmetics intended to support the appearance of healthy-looking skin. They are not therapeutic goods and are not intended to treat, cure, or prevent any condition.

Stay close

We launch in mid-2026. Waitlist opens 15% off your first order.

Join the waitlist